TRAVERE THERAPEUTICS, INC. (TVTX) Operating income 2016–2025
TRAVERE THERAPEUTICS, INC. (TVTX) annual operating income history from SEC filings — each fiscal year as reported.
-$62.8MFY2025 · since FY2016: -$58.2M → -$62.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.8M | +80.6% |
| FY2024 | -$323.8M | +16.6% |
| FY2023 | -$388.1M | -21.4% |
| FY2022 | -$319.8M | -60.4% |
| FY2021 | -$199.4M | -13.2% |
| FY2020 | -$176.2M | -28.2% |
| FY2019 | -$137.4M | -71.6% |
| FY2018 | -$80.0M | -48.8% |
| FY2017 | -$53.8M | +7.6% |
| FY2016 | -$58.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice